PrimeVax Immuno-Oncology is a biotechnology company developing one-time one-week cancer treatments.
PrimeVax Immuno-Oncology is a biotechnology company developing one-time one-week cancer treatments that is headquartered in Orange, California and was founded in 2015 by Boris Minev and Santosh Kesari.
PrimeVax Immuno-Oncology is a interested in creating treatments for cancer that utilize the entire body and personalized neo-antigens. The company worked with the combination of the dengue fever virus and autologous dendritic cells in order to create and induce a strong immune response with personalized tumor targeting. This process is part of their one-time, one-week cancer treatment.
January 22, 2019